Clinical Trial Update: Immunogenicity, Safety and Protective Effect of Live Attenuated Varicella Vaccine and Study on Antibody Level and Etiology of Varicella Zoster Virus [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating immunogenicity, safety, and protective effect of a live attenuated varicella vaccine with antibody level and etiology analysis f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Varicella

Drugs mentioned

• Varicella vaccine (live attenuated) by Sinovac (Dalian) Vaccine Technology Co., Ltd.

Snippet

Sponsor: Sinovac (Dalian) Vaccine Technology Co., Ltd. | Conditions: Varicella | Phase 4 | Status: UNKNOWN